Ketamine Rapidly Reduces Depression, According To 'Most Comprehensive Review' Of Evidence — But Patient Experiences Suggest More Applications
Psychedelic Companies Keenly Aware Of Creating Therapies As Healthcare Reimbursement Possibility Looms
Psyched: Novamind Partners With Merck, Atai Expands To Japan, Australia Funds Psychedelics Research
Field Trip Secures $76M For Psychedelics Clinics, Drug Development
Field Trip Health Recent News
The Horizons Psychedelic Stock Index ETF, As Told By Its Fund Manager
Psyched: First Psychedelics ETF Debuts; Hawaii, Florida and Connecticut Eye Psilocybin Legalization; Psyence Goes Public
Psyched: NeonMind, Novamind Go Public; MAPS And Field Trip Study MDMA, Psychedelics Center Launches In NYC
Psyched: Canada Allows Psilocybin Use For Healthcare Pros, UK Begins DMT Trials, Cybin To Purchase Adelia
Psyched: German Government Funds Psilocybin Study, Field Trip Opens Psilocybin Clinic
Psyched: Oregon Legalizes Psilocybin, Washington DC Decriminalizes Psychedelics, Cybin And Entheon To Go Public
Psyched: St. Vincent OKs Psychedelics Program, Delic To Go Public, Field Trip Drug Update
Psyched: Cybin Raises CA$45M, Numinus Harvests Legal Mushrooms, Toadstool Enters Psychedelic Space
Field Trip Health Begins Trading On CSE: Chairman Provides Company Overview
Psychedelic-Enhanced Psychotherapy Clinic Opens In Toronto